It has been recently reported that CD8+TRM possess potent tumor-killing capabilities and can promote the colocalization of T cells with B cells and dendritic cells, and the accumulation in TC shows a significant correlation with the efficacy of ICB (53, 54). This evidence concerns the gene CD8A and neoplasm.